PhytoTech merger to target global growth

Company News

by Lelde Smitts

Shares in PhytoTech Medical Limited (ASX:PYL) rose 11.5 per cent yesterday after announcing a merger of equals with Canada’s MMJ Biosceience Inc. 
 
The transaction will see PhytoTech acquire 100 per cent of the issued capital of MMJ to create a global vertically integrated medical cannabis company. 
 
The deal consideration is $15.5 million of PhytoTech’s scrip, based on its last traded price, and an extra $5.2 million in performance shares based on meeting milestones. 
 
PhytoTech expects the combined entity to be involved with the production, research, development and distribution of medical cannabis products. 
 
PhytoTech Medical was the first medical marijuana company to list on the ASX in January 2015. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.